Oropouche virus threat looms as cases hit Germany, Italy, Spain
New cases of the virus, which previously spread in South America, have been reported in Europe. Experts warn of its dangerous effects, including meningitis. Europe may be at risk of an epidemic.
What do you need to know?
- The Oropouche virus, also known as "sloth fever", has been detected in Germany, Italy, and Spain. However, all cases so far originated from infections outside Europe.
- Symptoms of the infection include high fever, muscle aches, and nausea. In extreme cases, the virus can cause meningitis.
- The virus poses a significant threat, especially to pregnant women. There is currently no vaccine that offers protection against infection.
What are the symptoms of the Oropouche virus?
The Oropouche virus, also known as "sloth fever," manifests with high fever, muscle aches, nausea, and a skin rash. These symptoms can appear three to ten days after infection. Although they may seem mild at first, the virus can lead to serious complications, such as meningitis. The European Center for Disease Prevention and Control (ECDC) emphasizes that fatal cases are rare, but the lack of effective treatment remains a problem.
The Oropouche virus was first identified in 1955 in a 24-year-old forestry worker on the island of Trinidad. This virus was found in three-toed sloths. It's possible that these animals may play a role in transmitting the infection between insects and other animals.
Can the Oropouche virus spread in Europe?
Experts warn that the Oropouche virus is more dangerous than previously thought. Over the past year, it has spread rapidly in South America and is now appearing in Europe. The virus is transmitted through bites from certain types of midges and mosquitoes, which means people in forested areas are particularly at risk.
So far, nearly 20 cases have been confirmed in Europe in countries such as Germany, Italy, and Spain. However, all infections have occurred outside the continent.
What are the risks associated with the Oropouche virus?
The Oropouche virus can lead to serious health complications, including miscarriages and birth defects, posing a particular threat to pregnant women. About 4% of those infected develop encephalitis or meningitis, which can result in serious neurological problems. Experts emphasize that the lack of a vaccine and effective treatment makes the virus a significant threat to public health.
